Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Hélène Dulude"'
Autor:
Cristina B. Guzman, Vincent Woo, S.J. Weisnagel, Xiaotian M. Zhang, Sheetal Pradhan, Gregg Gerety, George Tsoukas, Shuyu Zhang, Claude A. Piché, Elizabeth R. Seaquist, James R. Conway, Rémi Rabasa-Lhoret, Hélène Dulude, Dolorès Carballo
Publikováno v:
Diabetes, Obesity & Metabolism
In the present multicentre, open-label, prospective, phase III study, we evaluated the real-world effectiveness and ease of use of nasal glucagon (NG) in the treatment of moderate/severe hypoglycaemic events (HEs) in adults with type 1 diabetes (T1D)
Autor:
Xiaotian Michelle Zhang, Barry Reiner, Cristina B. Guzman, Sheetal Pradhan, Hélène Dulude, Shuyu Zhang, Claude A. Piché, Larry C. Deeb
Publikováno v:
Pediatric Diabetes. 19:1007-1013
OBJECTIVE This multicenter, open-label study was designed to evaluate real-world effectiveness and ease of use of nasal glucagon (NG) in treating moderate or severe hypoglycemic events in children and adolescents with type 1 diabetes (T1D). METHODS C
Autor:
Maryam Tafreshi, Emmanouil Rampakakis, Myriam Triest, Marianne Rufiange, Aziz A. Sadoune, Shuyu Zhang, Hélène Dulude, Claude A. Piché, Eric Sicard, Cristina B. Guzman, Michelle Xiaotian Zhang, Dolorès Carballo
Publikováno v:
Diabetes, Obesity & Metabolism
Aims Nasal glucagon (NG) is a nasally-administered glucagon powder, absorbed through the nasal mucosa, designed for treatment of severe hypoglycaemia. This study evaluated the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of NG in otherwise
Autor:
William V. Tamborlane, Katrina J. Ruedy, Linda A. DiMeglio, Roy W. Beck, Jennifer L. Sherr, Claude A. Piché, Hélène Dulude, Linyan Meng, Emmanouil Rampakakis, Santica M. Marcovina, R. Paul Wadwa, Kathleen E. Bethin, Nicole C. Foster, Larry A. Fox, Desmond A. Schatz, Michael R. Rickels, Brandon M. Nathan
Publikováno v:
Diabetes Care
OBJECTIVE Treatment of severe hypoglycemia outside of the hospital setting is limited to intramuscular glucagon requiring reconstitution prior to injection. The current study examined the safety and dose-response relationships of a needle-free intran
Autor:
R. Paul Wadwa, Brandon M. Nathan, Katrina J. Ruedy, Linda A. DiMeglio, Nicole C. Foster, Santica M. Marcovina, Kathleen E. Bethin, Michael R. Rickels, Jennifer L. Sherr, Roy W. Beck, Andrew J. Ahmann, Michael J. Haller, William V. Tamborlane, Hélène Dulude, Linyan Meng, Emmanouil Rampakakis, Claude A. Piché
Publikováno v:
Diabetes Care
OBJECTIVE Treatment of severe hypoglycemia with loss of consciousness or seizure outside of the hospital setting is presently limited to intramuscular glucagon requiring reconstitution immediately prior to injection, a process prone to error or omiss
Autor:
Hélène Dulude, Shuyu Zhang, Larry C. Deeb, Xiaotian Michelle Zhang, Claude A. Piché, Sheetal Pradhan, Cristina B. Guzman, Barry Reiner
Publikováno v:
Yearbook of Paediatric Endocrinology.
Autor:
Dolorès Carballo, Cristina B. Guzman, Adam Shames, Martin Lafontaine, Jean-François Yale, Rebecca Margolies, Shuyu Zhang, Michelle Xiaotian Zhang, Hélène Dulude, Claude A. Piché, Marc Egeth, Nicole Kaplowitz, Emily Dissinger
Publikováno v:
Diabetes Technology & Therapeutics
Background: During severe hypoglycemic episodes, people with diabetes depend on others to help with treatment. We compared needle-free nasal glucagon and commercially available injectable glucagon for ease of use by caregivers of people with diabetes
Autor:
Shafaat A. Rabbani, Jinzi J. Wu, Hélène Dulude, Luc Daigneault, Jean-Christophe Currie, Chandra J. Panchal, Seema Garde, Richard Béliveau, Borhane Annabi, Mounia Bouzeghrane
Publikováno v:
Biochemical and Biophysical Research Communications. 346:358-366
Purpose PCK3145 is an anti-metastatic synthetic peptide with promising therapeutic efficacy against hormone-refractory prostate cancer. The characterization of the PCK3145 peptide cell surface binding/internalization mechanisms and of the receptors i
Autor:
Hélène Dulude, Robert K. Nam, John Trachtenberg, Marjan Emami, Ants Toi, Jonathan R. Reeves, Steven A. Narod, Chandra J. Panchal, Luc Daigneault, Linda Sugar, Michael Jewett
Publikováno v:
Journal of Urology. 175:1291-1297
Purpose: New biomarkers for prostate cancer are needed. We determined whether a novel serum marker, total PSP94 can be used to accomplish these goals.Materials and Methods: We conducted a case-control study of 1,212 men with no previous history of pr
Autor:
Jinzi J. Wu, Borhane Annabi, Seema Garde, Hélène Dulude, Luc Daigneault, Chandra J. Panchal, Mounia Bouzeghrane, Shafaat A. Rabbani, Richard Béliveau, Jean-Christophe Currie
Publikováno v:
Anti-Cancer Drugs. 17:429-438
PCK3145 is a synthetic peptide corresponding to amino acids 31-45 of prostate secretory protein 94 which can reduce experimental skeletal metastases and prostate tumor growth. These anti-metastatic and anti-tumoral effects of PCK3145 are partially ex